Amicus Therapeutics, Inc. (0HF9.L)
USD 9.86
(-1.0%)
USD 9.86
(-1.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -69.09 Million | -166.57 Million | -202.49 Million | -233.29 Million | -250.41 Million | -299.95 Million |
| Net Income | -151.58 Million | -236.56 Million | -250.46 Million | -276.85 Million | -356.38 Million | -348.99 Million |
| Depreciation & Amortization | 7.87 Million | 5.34 Million | 6.2 Million | 8.84 Million | 4.77 Million | 4.21 Million |
| Deferred income taxes | -4.93 Million | 9000.00 | 34 Thousand | -155 Thousand | -1.41 Million | 6.01 Million |
| Stock-based compensation | 86.07 Million | 76.51 Million | 57.83 Million | 49.15 Million | 44.43 Million | 29.26 Million |
| Change in working capital | -47.99 Million | -39.88 Million | -18.58 Million | -32.06 Million | 11.61 Million | -4.72 Million |
| Other non-cash items | 41.47 Million | 28.01 Million | 2.47 Million | 17.78 Million | 46.57 Million | 14.27 Million |
| Investing Cash Flow | 98.06 Million | 92.31 Million | 78.76 Million | -13.57 Million | 95.15 Million | -121.2 Million |
| Investments in PPE | -7.44 Million | -3.76 Million | -3.88 Million | -3.22 Million | -20.01 Million | -6.3 Million |
| Acquisitions | -105.5 Million | 3.41 Million | 3.88 Million | 3.22 Million | 20.01 Million | 6.3 Million |
| Investment purchases | -91.72 Million | -243.25 Million | -341.39 Million | -365.17 Million | -383.88 Million | -578.39 Million |
| Sales/Maturities of investments | 197.22 Million | 335.92 Million | 424.04 Million | 354.82 Million | 499.04 Million | 463.5 Million |
| Other Investing Activities | 105.5 Million | 3.41 Million | -3.88 Million | -3.22 Million | -20.01 Million | -6.3 Million |
| Financing Cash Flow | 61.67 Million | -7.46 Million | 212.07 Million | 262.85 Million | 217.5 Million | 450.77 Million |
| Debt repayment | -20.95 Million | -283 Thousand | -479 Thousand | -155.32 Million | -420 Thousand | -334 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -17.92 Million | -11.49 Million | -15 Million | -10.02 Million | -3.23 Million | -2.83 Million |
| Common Stock Issuance | 103.2 Million | 4.31 Million | 199.75 Million | 42.28 Million | 188.99 Million | 294.58 Million |
| Other Financing Activities | -20.57 Million | 4.31 Million | 42.82 Million | 418.18 Million | 35.39 Million | 156.52 Million |
| Accounts receivables | -20.1 Million | -17.33 Million | -8.18 Million | -11.21 Million | -11.11 Million | -13.29 Million |
| Accounts payables | 49.19 Million | -6.37 Million | 7.43 Million | -10.61 Million | 46.74 Million | 17.11 Million |
| Inventory | -44.61 Million | -5.34 Million | -7.79 Million | -4.63 Million | -5.11 Million | -4.2 Million |
| Other working capital | -32.46 Million | -10.83 Million | -10.03 Million | -5.59 Million | -18.9 Million | -4.34 Million |
| Cash at beginning of period | 148.81 Million | 249.45 Million | 166.16 Million | 146.34 Million | 82.37 Million | 51.23 Million |
| Cash at end of period | 246.99 Million | 153.11 Million | 249.45 Million | 166.16 Million | 146.34 Million | 82.37 Million |
| Capital Expenditure | -7.44 Million | -3.76 Million | -3.88 Million | -3.22 Million | -20.01 Million | -6.3 Million |
| Effect of forex changes on cash | 6.31 Million | -14.61 Million | -5.04 Million | 3.83 Million | 1.72 Million | 1.51 Million |
| Net cash flow / Change in cash | 98.18 Million | -96.34 Million | 83.29 Million | 19.81 Million | 63.96 Million | 31.13 Million |
| Free Cash Flow | -76.53 Million | -170.34 Million | -206.37 Million | -236.51 Million | -270.42 Million | -306.26 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -15.69 Million | -48.41 Million | -33.84 Million | -151.58 Million | -21.57 Million | -43.23 Million |
| Depreciation & Amortization | 2.18 Million | 2.15 Million | 2.18 Million | 7.87 Million | 2.22 Million | 2.2 Million |
| Deferred income taxes | - | 4.83 Million | -28.24 Million | -4.93 Million | 3.12 Million | 20.07 Million |
| Stock-based compensation | 16.19 Million | 30.8 Million | 18.09 Million | 86.07 Million | 16.51 Million | 16.57 Million |
| Change in working capital | 11.09 Million | -22.31 Million | 696 Thousand | -47.99 Million | -32.74 Million | -4.85 Million |
| Other non-cash items | 37.58 Million | 59.8 Million | 44.56 Million | 41.47 Million | -5.89 Million | -6.9 Million |
| Investing Cash Flow | -21.97 Million | 7.53 Million | -23.95 Million | 98.06 Million | 35.76 Million | 50 Million |
| Investments in PPE | -1.09 Million | -1.81 Million | -1.73 Million | -7.44 Million | -1.56 Million | -2.2 Million |
| Acquisitions | - | - | 22.22 Million | -105.5 Million | 1.56 Million | 2.2 Million |
| Investment purchases | -44.3 Million | -29.55 Million | -38.62 Million | -91.72 Million | -16.65 Million | -19.7 Million |
| Sales/Maturities of investments | 23.42 Million | 38.9 Million | 16.39 Million | 197.22 Million | 53.98 Million | 71.9 Million |
| Other Investing Activities | -1.09 Million | 9.34 Million | -22.22 Million | 105.5 Million | -1.56 Million | -2.2 Million |
| Financing Cash Flow | -857 Thousand | -13.3 Million | 8.21 Million | 61.67 Million | 37.61 Million | 23.67 Million |
| Debt repayment | -36 Thousand | -42 Thousand | -20.87 Million | -20.95 Million | -31 Thousand | -23 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -16.72 Million | -1.56 Million | -17.92 Million | -2.34 Million | -1.2 Million |
| Common Stock Issuance | 863 Thousand | 3.45 Million | 32.24 Million | 103.2 Million | 36.55 Million | 24.19 Million |
| Other Financing Activities | -1.68 Million | -16.72 Million | -3.15 Million | -20.57 Million | 5.78 Million | 1.9 Million |
| Accounts receivables | -10 Million | 9.55 Million | -11.49 Million | -20.1 Million | -11.31 Million | 4.07 Million |
| Accounts payables | 27.12 Million | -24.48 Million | 8.09 Million | 49.19 Million | 9.48 Million | 31.69 Million |
| Inventory | -25.22 Million | -1.67 Million | -2.38 Million | -44.61 Million | -14.75 Million | -24.32 Million |
| Other working capital | 19.19 Million | -5.71 Million | 6.47 Million | -32.46 Million | -16.15 Million | -16.29 Million |
| Cash at beginning of period | 209.76 Million | 246.99 Million | 263.32 Million | 148.81 Million | 214.33 Million | 164.98 Million |
| Cash at end of period | 209.33 Million | 209.76 Million | 246.99 Million | 246.99 Million | 266.27 Million | 214.33 Million |
| Capital Expenditure | -1.09 Million | -1.81 Million | -1.73 Million | -7.44 Million | -1.56 Million | -2.2 Million |
| Effect of forex changes on cash | -294 Thousand | -1.81 Million | -3.9 Million | 6.31 Million | 16.9 Million | -8.19 Million |
| Net cash flow / Change in cash | -426 Thousand | -37.23 Million | -16.32 Million | 98.18 Million | 51.93 Million | 49.35 Million |
| Free Cash Flow | 21.59 Million | -31.5 Million | 1.72 Million | -76.53 Million | -39.91 Million | -18.33 Million |
0369
KANSHST
ERIC-B
003380
HAKI-B
PHRX